Evogene Ltd. (TLV: EVGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA
471.00
+19.00 (4.20%)
Dec 19, 2024, 5:24 PM IDT
Evogene Revenue
Evogene had revenue of $1.80M USD in the quarter ending September 30, 2024, a decrease of -52.32%. This brings the company's revenue in the last twelve months to $7.48M, up 30.69% year-over-year. In the year 2023, Evogene had annual revenue of $5.64M with 236.72% growth.
Revenue (ttm)
$7.48M
Revenue Growth
+30.69%
P/S Ratio
0.89
Revenue / Employee
$52.66K
Employees
142
Market Cap
32.03M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
Dec 31, 2019 | 753.00K | -994.00K | -56.90% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEvogene News
- 4 weeks ago - Evogene Ltd (EVGN) Q3 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus
- 4 weeks ago - Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Evogene GAAP EPS of -$1.31 misses by $0.30, revenue of $1.8M misses by $1.05M - Seeking Alpha
- 4 weeks ago - Evogene Reports Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Evogene Q3 2024 Earnings Preview - Seeking Alpha
- 4 weeks ago - A Glimpse of Evogene's Earnings Potential - Benzinga
- 4 weeks ago - Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - PRNewsWire
- 5 weeks ago - Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - PRNewsWire